Respiratory Syncytial Virus (RSV) Vaccines for Adults
Customize your policy alerts
Sign up for all CareFirst policy alerts
Know when CareFirst releases new policies or updates existing guidance.
Monitor payer policy activity
Defines medical necessity and coverage criteria for RSV vaccines (Abrysvo, Arexvy, mRESVIA) in adults and for Abrysvo in pregnancy, for CareFirst-managed benefits.
Policy updated to adopt FDA approvals for Abrysvo and mRESVIA in high-risk adults aged 18-74, and to remove mRESVIA from the experimental/investigational designation.
ACIP updated recommended age of adults at increased risk from 60-74 to 50-74, but the policy adheres to FDA-approved age ranges for certain vaccines.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.